Chisato Murata
Tokai University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Chisato Murata.
Diabetes Care | 1996
Yoshihiko Suzuki; Taro Muramatsu; Matsuo Taniyama; Yoshihito Atsumi; Makoto Suematsu; Ryuji Kawaguchi; Susumu Higuchi; Takayuki Asahina; Chisato Murata; Michiko Handa; Kempei Matsuoka
OBJECTIVE To ascertain why alcohol is prone to manifest unpleasant effects in diabetes associated with mitochondrial tRNALeu(UUR) mutation at position 3243 (DM-Mt3243), we investigated the genotype of aldehyde dehydrogenase (ALDH) 2 and alcohol dehydrogenase 2 (ADH2) in DM-Mt3243. RESEARCH DESIGN AND METHODS Nineteen unrelated patients with DM-Mt3243 were included in the study (12 men and 7 women). They were recruited from ∼700 diabetic patients at three different institutes, without prior information of alcohol habit. ALDH2, ADH2, and 3243 mutation were genotyped by polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) methods. There were 461 unrelated Japanese individuals and 170 non-3243 mutant NIDDM patients enrolled as control subjects. RESULTS In the DM-Mt3243 group, 15 (79%) patients had inactive ALDH2 and 18 (95%) had atypical ADH2. The frequency of the inactive ALDH2 genotype was higher than that in the normal control subjects (P < 0.002) and that in the NIDDM control subjects (P < 0.003). However, the frequencies of ADH2 genotype in the DM-Mt3243 group, the normal control subjects, and the NIDDM control subjects were not different. CONCLUSIONS Inactive ALDH2 genotype was frequently observed in DM-Mt3243. It suggests that DM-Mt3243 is associated with ALDH2 inactivity. We speculate the trait of acetaldehyde accumulation on ALDH2 inactivity may favor mitochondrial DNA abnormalities, thereby worsening ATP production and impairing insulin secretion. In addition, the interaction of ALDH1 and ALDH2 may alter the retinoid metabolism in the pancreas, thereby influencing insulin secretion and precipitating diabetes. Thus, this association of ALDH2 genotype with DM-Mt3243 provides insight into the etiology of diabetes in the mitochondrial diseases.
Metabolism-clinical and Experimental | 2003
Chisato Murata; Tetsu Watanabe; Hiroyuki Furuya; Yoshihiko Sugioka; Hajime Mikurube; Akira Yokoyama; Yoshihito Atsumi; Kempei Matsuoka; Isao Okazaki
Recent studies indicate that some patients with nonalcoholic fatty liver have ongoing liver injury that may progress from steatosis to steatohepatitis or fibrosis. The present study was designed to clarify the clinical features of liver dysfunction observed in the course of workplace physical check-ups in relation to multiple risk factor syndrome including obesity, hyperlipidemia, hypertension, and impaired glucose tolerance, and to clarify the involvement of aldehyde dehydrogenase 2 (ALDH2) and beta(3)-adrenergic receptor (beta3-AR) gene polymorphisms in elevation of liver enzymes. One hundred forty-eight male workers 35 years of age were enrolled. They were requested to answer questionnaires about drinking and smoking habits, and underwent urinalysis, physical and peripheral blood examinations, blood chemistry, electrocardiogram and chest x-rays. The genotypes of ALDH2 and beta3-AR were analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The subjects were divided into active ALDH2 or inactive ALDH2 groups. They were also divided into 2 groups according to the beta3-AR genotype. The relationships between ALDH2 and beta3-AR gene polymorphism and the results of the physical examination including liver function tests were analyzed. The subjects were also divided according to the number of components of metabolic syndrome. The prevalence of elevated alanine aminotransferase (ALT) level increased with the accumulation of components of metabolic syndrome. Active ALDH2 was associated with elevated ALT level to a greater degree than beta3-AR polymorphism. Among those with normal body mass index (BMI), the genotypes of ALDH2 and beta3-AR were strongly associated with elevated ALT level. Logistic regression analysis revealed that BMI, triglyceride level, and ALDH2 genotype were associated with ALT elevation. In conclusion, evaluating the genotype of ALDH2 and beta3-AR may assist in predicting and preventing the development of fatty liver which may be related to multiple risk factor syndrome.
Endocrine Journal | 1995
Yoshihiko Suzuki; Hiroko Kadowaki; Yoshihito Atsumi; Kazuhiro Hosokawa; Hideki Katagiri; Takashi Kadowaki; Yoshitomo Oka; Keiko Uyama; Atsuko Mokubo; Takayuki Asahina; Chisato Murata; Kempei Matsuoka
Alcoholism: Clinical and Experimental Research | 2000
Chisato Murata; Yoshihiko Suzuki; Taro Muramatsu; Matsuo Taniyama; Yoshihito Atsumi; Kempei Matsuoka; Tetsu Watanabe; Isao Okazaki
Diabetes Research and Clinical Practice | 2004
Chisato Murata; Matsuo Taniyama; Satoru Kuriyama; T. Muramatsu; Y. Atsumi; K. Matsuoka; Y. Suzuki
Diabetes Research and Clinical Practice | 2003
Yuko Suzuki; S. Kuriyama; Y. Atsumi; Chisato Murata; K. Matsuoka; Matsuo Taniyama; T. Muramatsu; Shigeo Ohta
Biochemical and Biophysical Research Communications | 2003
Yukihiko Momiyama; Michiko Furutani; Yoshihiko Suzuki; Reiko Ohmori; Shinichiro Imamura; Atsuko Mokubo; Takayuki Asahina; Chisato Murata; Kiyoe Kato; Sonoko Anazawa; Kazuhiro Hosokawa; Yoshihito Atsumi; Kempei Matsuoka; Mitsuru Kimura; Hiroshi Kasanuki; Fumitaka Ohsuzu; Rumiko Matsuoka
Japanese journal of public health | 2005
Hajime Mikurube; Mitsunobu Kaneko; Chisato Murata; Yoko Komaki; Noriko Ishikawa; Reiichi Higashiyama; Kenji Fukasawa; Tetsu Watanabe
Diabetes Care | 2003
Yoshihiko Suzuki; Matsuo Taniyama; T. Muramatsu; Shigeo Ohta; Chisato Murata; Yoshihito Atsumi; Kempei Matsuoka
Diabetes Research and Clinical Practice | 2004
Y. Suzuki; Yoshitomo Oka; Matsuo Taniyama; Chisato Murata; Y. Atsumi; K. Matsuoka